{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:05:50Z","timestamp":1780092350663,"version":"3.54.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jid.2022.04.017","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T20:02:32Z","timestamp":1651867352000},"page":"3009-3019.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-6456","authenticated-orcid":false,"given":"Mario","family":"Picozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-2485","authenticated-orcid":false,"given":"Cristina","family":"Cristofoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3954-5481","authenticated-orcid":false,"given":"Antonella","family":"Bresin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-706X","authenticated-orcid":false,"given":"Martina","family":"Fioretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-7327","authenticated-orcid":false,"given":"Manolo","family":"Sambucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-9168","authenticated-orcid":false,"given":"Enrico","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-1405","authenticated-orcid":false,"given":"Alessandro","family":"Monopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4586-0920","authenticated-orcid":false,"given":"Maria","family":"Cantonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8757-3669","authenticated-orcid":false,"given":"Maria Antonietta","family":"Pilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1682-8286","authenticated-orcid":false,"given":"Maria Pina","family":"Accetturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-6481","authenticated-orcid":false,"given":"Giovanna","family":"Borsellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9852-7377","authenticated-orcid":false,"given":"Stefania","family":"D\u2019Atri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-4700","authenticated-orcid":false,"given":"Elisabetta","family":"Caprini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-9687","authenticated-orcid":false,"given":"Giandomenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8877-4611","authenticated-orcid":false,"given":"Maria Grazia","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.04.017_bib1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(19)30320-1","article-title":"IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial","volume":"20","author":"Bagot","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2022.04.017_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP.","volume":"37","author":"Becht","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2022.04.017_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jid.2018.09.026","article-title":"Identification of CD39 as a marker for the circulating malignant T-cell clone of S\u00e9zary syndrome patients","volume":"139","author":"Bensussan","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.04.017_bib4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib5","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.3892\/ol.2016.5189","article-title":"High expression of CD39 in gastric cancer reduces patient outcome following radical resection","volume":"12","author":"Cai","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jid.2022.04.017_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/med.21324","article-title":"Moonlighting adenosine deaminase: a target protein for drug development","volume":"35","author":"Cort\u00e9s","year":"2015","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jid.2022.04.017_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41375-018-0305-8","article-title":"Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K\/AKT\/mTORC1 pathway and its prognostic relevance","volume":"33","author":"Cristofoletti","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2022.04.017_bib8","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2013-06-510578","article-title":"Comprehensive analysis of PTEN status in Sezary syndrome","volume":"122","author":"Cristofoletti","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.04.017_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","article-title":"Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells","volume":"92","author":"D\u00f6bbeling","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.celrep.2016.01.002","article-title":"Expression of CD39 on activated T cells impairs their survival in older individuals","volume":"14","author":"Fang","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2022.04.017_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.1994.12.2.326","article-title":"Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sezary syndrome","volume":"12","author":"Foss","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2022.04.017_bib13","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1073\/pnas.0902869106","article-title":"From the cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease","volume":"106","author":"Friedman","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.04.017_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.33131","article-title":"Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions","volume":"147","author":"Gallerano","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2022.04.017_bib15","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood.2019000765","article-title":"Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with S\u00e9zary syndrome","volume":"134","author":"Gao","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/jid.2012.265","article-title":"Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for S\u00e9zary syndrome","volume":"133","author":"Gibson","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.04.017_bib17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u03b2 chain restriction","volume":"74","author":"Gibson","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2022.04.017_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.2020009346","article-title":"Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures","volume":"138","author":"Herrera","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.19.01056","article-title":"Pembrolizumab in relapsed and refractory mycosis fungoides and S\u00e9zary syndrome: a multicenter phase II study","volume":"38","author":"Khodadoust","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2022.04.017_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover","volume":"39","author":"Krejsgaard","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2022.04.017_bib21","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1158\/2159-8290.CD-19-0541","article-title":"Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity","volume":"9","author":"Li","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2022.04.017_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09546634.2019.1587144","article-title":"Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010\u20132015","volume":"31","author":"Ling","year":"2020","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.jid.2022.04.017_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/00016489.2017.1405278","article-title":"Ectonucleotidase CD39 expression in regional metastases in head and neck cancer","volume":"138","author":"Mandapathil","year":"2018","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jid.2022.04.017_bib24","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2007-06-095182","article-title":"IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes","volume":"111","author":"Marzec","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2350-15-73","article-title":"Genetic analysis of an allergic rhinitis cohort reveals an intercellular epistasis between FAM134B and CD39","volume":"15","author":"Melchiotti","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jid.2022.04.017_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fonc.2020.00514","article-title":"New insights into the complex mutational landscape of S\u00e9zary syndrome","volume":"10","author":"Mirza","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2022.04.017_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2022.04.017_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41375-020-0788-y","article-title":"Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function","volume":"35","author":"Nagate","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2022.04.017_bib29","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of S\u00e9zary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.579894","article-title":"Reduction of T lymphoma cells and immunological invigoration in a patient concurrently affected by melanoma and Sezary syndrome treated with nivolumab","volume":"11","author":"Narducci","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.04.017_bib31","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib32","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2022.04.017_bib33","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2020009655","article-title":"Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity","volume":"138","author":"Park","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib34","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2022.04.017_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of sezary syndrome","volume":"122","author":"Poszepczynska-Guign\u00e9","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.04.017_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clml.2011.06.005","article-title":"CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia","volume":"11","author":"Pulte","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jid.2022.04.017_bib37","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00262-020-02563-2","article-title":"Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients","volume":"69","author":"Qi","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2022.04.017_bib38","first-page":"1","article-title":"Single-cell heterogeneity of cutaneous T-cell lymphomas revealed using RNA-seq technologies","volume":"12","author":"Rassek","year":"2020"},{"key":"10.1016\/j.jid.2022.04.017_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2014.12.007","article-title":"The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation","volume":"58","author":"Rissiek","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2022.04.017_bib40","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/archdermatol.2010.200","article-title":"Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression","volume":"146","author":"Samimi","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2022.04.017_bib41","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3324\/haematol.2010.026260","article-title":"The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with S\u00e9zary syndrome","volume":"95","author":"Scala","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jid.2022.04.017_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1523-1747.2002.18194.x","article-title":"T cell receptor-V\u03b1 analysis identifies a dominant CD60+CD26-CD49d-T cell clone in the peripheral blood of S\u00e9zary syndrome patients","volume":"119","author":"Scala","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.04.017_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2018.01.076","article-title":"Blood classification and blood response criteria in mycosis fungoides and S\u00e9zary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force","volume":"93","author":"Scarisbrick","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2022.04.017_bib44","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2022.04.017_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/cco.2019.01.01","article-title":"Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and S\u00e9zary syndrome (SS)","volume":"8","author":"Shalabi","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.jid.2022.04.017_bib46","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood.2021014782","article-title":"Involvement of the CD39\/CD73\/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in S\u00e9zary syndrome.","volume":"139","author":"Sonigo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib47","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2022.04.017_bib48","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.neuropharm.2008.08.005","article-title":"The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition","volume":"55","author":"Wall","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jid.2022.04.017_bib49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ajh.24876","article-title":"Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Wilcox","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jid.2022.04.017_bib50","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2022.04.017_bib52","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1158\/0008-5472.CAN-09-2367","article-title":"Identification of key regions and genes important in the pathogenesis of S\u00e9zary syndrome by combining genomic and expression microarrays","volume":"69","author":"Caprini","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2022.04.017_bib53","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41375-018-0305-8","article-title":"Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K\/AKT\/mTORC1 pathway and its prognostic relevance","volume":"33","author":"Cristofoletti","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2022.04.017_bib54","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2013-06-510578","article-title":"Comprehensive analysis of PTEN status in Sezary syndrome","volume":"122","author":"Cristofoletti","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.04.017_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C[T]) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jid.2022.04.017_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2014.12.007","article-title":"The\u00a0expression of CD39 on regulatory T cells is genetically driven and\u00a0further upregulated at sites of inflammation","volume":"58","author":"Rissiek","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2022.04.017_bib57","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3324\/haematol.2010.026260","article-title":"The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with S\u00e9zary syndrome","volume":"95","author":"Scala","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jid.2022.04.017_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1523-1747.2002.18194.x","article-title":"T\u00a0cell receptor-V\u03b1 analysis identifies a dominant CD60+CD26-CD49d-T cell clone in the peripheral blood of S\u00e9zary syndrome patients","volume":"119","author":"Scala","year":"2002","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22003724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22003724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:49:58Z","timestamp":1762206598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X22003724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0022202X22003724"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.04.017","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742135997.793593048","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}